Patents by Inventor Mark A. Scheideler

Mark A. Scheideler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds
    Publication number: 20030220478
    Abstract: R35 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing R35 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: December 9, 2002
    Publication date: November 27, 2003
    Applicants: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Mahanandeeshwar Gattu, David Michalovich, Alastair Reith, Mark A. Scheideler, Ping Tsui, Paula F. Zaratin
  • Novel compounds
    Publication number: 20020165351
    Abstract: R35 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing R35 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: October 17, 2001
    Publication date: November 7, 2002
    Inventors: Mahanandeeshwar Gattu, David Michalovich, Alastair Reith, Mark A. Scheideler, Ping Tsui, Paula F. Zaratin
  • Nociceptin analogues
    Patent number: 5998375
    Abstract: The present invention relates to novel peptides, pharmaceutical compositions containing them, methods for preparing the compounds, use of the compounds for preparing medicaments for treating vasomotor disturbances, in particular the peripheral vasomotor effects known as hot flushes or hot flashes, and to a method of treating vasomotor disturbances.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: December 7, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Henning Th.o slashed.gersen, Kjeld Madsen, Uffe Bang Olsen, Nils Langeland Johansen, Mark Scheideler